Your account is not claimed yet. You can sign up with ORCID to claim your account.

Ja Min Byun

Scopus Author ID Scopus Author ID Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2015-2023
Publications (10 Years): 18

Top Venues

Therapeutic advances in hematology

Journal of Korean medical science

Journal of clinical medicine

PloS one

Seoul National University Hospital

Seoul National University College of Medicine (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Seoul National University Hospital Jun 1o 2019

South Korea

Clinical Assistant Professor :: Internal Medicine

Education History

Seoul National University College of Medicine - Feb 28o 2019

South Korea

PHD :: Translation medicine-hematology

Publications

Jun Liu, Suji Min, Dongchan Kim, Jihyun Park, Eunchae Park, Shanshan Pei, Youngil Koh, Dong-Yeop Shin, Ja Min Byun, Myunggon Ko, Sung Soo Yoon, Junshik Hong
Pharmacological GLUT3 salvage augments the efficacy of vitamin C-induced TET2 restoration in acute myeloid leukemia. Leukemia (2023)
Eun Hee Jung, Ja Min Byun, Dong-Yeop Shin, Young Rok Do, Jae-Cheol Jo, Sang Min Lee, Sung Soo Yoon
Mobilization of hematopoietic stem cells with lenograstim in multiple myeloma patients: Prospective multicenter observational study (KMM122). Cancer medicine (2023)
Nan Young Bae, Ja Min Byun, Chang Kyung Kang, Pyoeng Gyun Choe, Nam Joong Kim, Min-Sung Kim, Kyu Joo Park, Sung-Soo Yoon
Successful treatment of angioinvasive aspergillosis causing diaphragmatic rupture with bowel perforation and cerebral aspergillosis in a patient with FLT3-mutated acute myeloid leukemia: A case report. Medicine 101 (4) (2022)
Hyun Jin Ahn, Ja Min Byun, Inho Kim, Jeonghwan Youk, Youngil Koh, Dong-Yeop Shin, Junshik Hong, Sung Soo Yoon
Eltrombopag for Post-Transplant Poor Graft Function in East Asian Patients. Journal of Korean medical science 37 (6) (2022)
Hyunkyung Park, Ja Min Byun, Sung Soo Yoon, Youngil Koh, Sock-Won Yoon, Dong-Yeop Shin, Junshik Hong, Inho Kim
Cyclophosphamide addition to pomalidomide/dexamethasone is not necessarily associated with universal benefits in RRMM. PloS one 17 (1) (2022)
Ja Min Byun, Dong-Yeop Shin, Youngil Koh, Junshik Hong, Inho Kim, Sung-Soo Yoon, Soo-Mee Bang, Jeong-Ok Lee
Should patients receive consolidation chemotherapy before reduced intensity allogeneic hematopoietic stem cell transplantation for acute myeloid leukemia in first complete remission? Therapeutic advances in hematology 12 (2021)
Hyun Kyu Kim, Su Young Son, Jae Sang Oh, Ye Na Song, Ja Min Byun, Youngil Koh, Junshik Hong, Sung Soo Yoon, Choong Hwan Lee, Dong-Yeop Shin, Man-Ryul Lee
Metabolic Profiling during Acute Myeloid Leukemia Progression Using Paired Clinical Bone Marrow Serum Samples. Metabolites 11 (9) (2021)
Song Lee Bak, Dong-Yeop Shin, Junshik Hong, Inho Kim, Youngil Koh, Ja Min Byun, Sung-Soo Yoon
Busulfan plus melphalan versus melphalan alone conditioning regimen after bortezomib based triplet induction chemotherapy for patients with newly diagnosed multiple myeloma. Therapeutic advances in hematology 12 (2021)
Jeongmin Seo, Dong-Yeop Shin, Youngil Koh, Inho Kim, Sung-Soo Yoon, Ja Min Byun, Junshik Hong
Association between preconditioning absolute lymphocyte count and transplant outcomes in patients undergoing matched unrelated donor allogeneic hematopoietic stem cell transplantation with reduced-intensity conditioning and anti-thymocyte globulin. Therapeutic advances in hematology 12 (2021)
Ja Min Byun, Junshik Hong, Doyeun Oh, Ho-Young Yhim, Young Rok Do, Joon Seong Park, Chul Won Jung, Deok-Hwan Yang, Jong-Ho Won, Hong Ghi Lee, Joon Ho Moon, Yeung-Chul Mun, Deog-Yeon Jo, Jae Joon Han, Je-Hwan Lee, Jae Hoon Lee, Junglim Lee, Sung Soo Yoon
Optimizing Preparative Regimen for Umbilical Cord Blood Transplantation in Adult Acute Leukemia Patients: Acute Lymphoblastic Leukemia Requires Myeloablative Conditioning but Not Acute Myeloid Leukemia. Journal of clinical medicine 9 (7) (2020)
Sung Soo Park, Ja Min Byun, Sung Soo Yoon, Kihyun Kim, Sung Hoon Jung, Je-Jung Lee, Chang-Ki Min
Daratumumab monotherapy for relapsed/refractory multiple myeloma, focussed on clinical trial-unfit patients and subsequent therapy. British journal of haematology 193 (1) (2020)
Ja Min Byun, Sung-Soo Yoon, Youngil Koh, Chang-Ki Min, Jae Hoon Lee, Jaemin Jo, Hyunkyung Park, Jiyun Lee, Ka-Won Kang, Yoojin Lee, null null
Incorporating hematopoietic stem-cell transplantation after second-line carfilzomib-lenalidomide-dexamethasone (KRd). Therapeutic advances in hematology 11 (2020)
Hoi Soo Yoon, Yujin Han, Young-Jin Kim, Min Jin Kim, Ja Min Byun, Tae-Mi Youk, Jae Hee Lee, Tae Sung Park, Jongha Yoo
Epidemiology of Congenital Bleeding Disorders: a Nationwide Population-based Korean Study. Journal of Korean medical science 35 (39) (2020)
Hyunkyung Park, Ja Min Byun, Sung Soo Yoon, Youngil Koh, Dong-Yeop Shin, Junshik Hong, Inho Kim
Allogeneic Stem Cell Transplantation in Relapsed/Refractory Multiple Myeloma Treatment: Is It Still Relevant? (Running Title: The Role of Salvage alloSCT in MM). Journal of clinical medicine 9 (8) (2020)
Ja Min Byun, Young Nam Kwon, Youngil Koh, Sung-Soo Yoon, Jung-Joon Sung, Inho Kim
Distinctive patterns of peripheral neuropathy across the spectrum of plasma cell disorders. Scientific reports 9 (1) (2019)
Ja Min Byun, Dong-Yeop Shin, Junshik Hong, Inho Kim, Hyun Kyung Kim, Dong Soon Lee, Youngil Koh, Sung-Soo Yoon
Distinct predictive impact of FISH abnormality in proteasome inhibitors and immunomodulatory agents response: redefining high-risk multiple myeloma in Asian patients. Cancer medicine 7 (3) (2018)
Ja Min Byun, Hea-Lim Kim, Dong-Yeop Shin, Youngil Koh, Sung-Soo Yoon, Moon-Woo Seong, Sung Sup Park, Jin Hee Kim, Yun-Gyoo Lee, Inho Kim
The Impact of Methylenetetrahydrofolate Reductase C677T Polymorphism on Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation with Methotrexate Prophylaxis. PloS one 11 (10) (2016)
Ja Min Byun, Chang Kyun Lee, Sang Youl Rhee, Hyo Jong Kim, Jung Wook Kim, Jae-Jun Shim, Jae Young Jang
The risk of tuberculosis in Korean patients with inflammatory bowel disease receiving tumor necrosis factor-α blockers. Journal of Korean medical science 30 (2) (2015)

Ja Min Byun.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Ja Min Byun